A Review of Insights on Vaccination Against Respiratory Viral Infections in Africa: Challenges, Efforts, Impacts, and Opportunities for the Future.

Paul Gasana, Noel Gahamanyi, Augustin Nzitakera, Frédéric Farnir, Daniel Desmecht, Leon Mutesa

Abstract readReview

In one paragraph

Review in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

'I Think From the Beginning, the Ambitions Were Compromised': A Case Study of COVAX as Vaccine Equity Policy Operationalisation.The International journal of health planning and management · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paul GasanaDepartment of Biomedical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Remera Campus-KG 11 Ave. 47, Kigali P.O. Box 4285, Rwanda.ORCID 0009-0006-4371-040X

Noel GahamanyiNational Reference Laboratory, Rwanda Biomedical Centre, Kigali P.O. Box 7162, Rwanda.ORCID 0000-0001-7813-6440

Augustin NzitakeraDepartment of Biomedical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Remera Campus-KG 11 Ave. 47, Kigali P.O. Box 4285, Rwanda.ORCID 0000-0002-7871-3954

Frédéric FarnirDepartment of Genetics, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.ORCID 0000-0003-3430-9930

Daniel DesmechtUnit of Pathology, Department of Morphology and Pathology, Faculty of Veterinary Medicine, University of Liège, 20 Boulevard de Colonster, 4000 Liège, Belgium.ORCID 0000-0001-9440-0993

Leon MutesaCenter for Human Genetics, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Remera Campus-KG 11 Ave. 47, Kigali P.O. Box 4285, Rwanda.ORCID 0000-0002-5308-3706

Funding

University of Rwanda-Academie de Recherche et d'Enseignement Superieur UR-ARES ARES-COOP-CONV-22-099

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Africalocal vaccine productionnational immunization programsrespiratory viral infectionsvaccine accessvaccine hesitancy

Identifiers

PMID41012094

DOI10.3390/vaccines13090888

PMCPMC12474198

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.